Rothschild & Co. Redburn Downgrades Danaher Corporation (DHR) to Hold, Reduces PT

​Danaher Corporation (NYSE:DHR) is one of the Best Forever Stocks to Invest In Now. On October 8, Ed Ridley from Rothschild & Co. Redburn downgraded Danaher Corporation (NYSE:DHR) from Buy to Hold, while also reducing the price target from $245 to $220.

​The firm noted that the company trades at a premium valuation (forward non-GAAP P/E ratio of 26.30). However, despite this premium valuation, the 2025 and 2026 growth outlook remains below the historic levels.

​Ridley believes that this valuation suggests that the company is returning to its historic growth levels in the life sciences market. However, he expressed concern regarding the limited visibility for the pace of recovery in China and the sustainability of diagnostic growth.

​Danaher Corporation (NYSE:DHR) is a global innovator in life sciences and diagnostics. It provides equipment, consumables, and services that support the research, development, and manufacturing of biological medicines.

While we acknowledge the potential of DHR as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.